
Aytu BioPharma’s Imminent Breakthrough: Can It Reach Profitability?
Aytu BioPharma, Inc. is experiencing significant financial improvement, reducing losses from $16 million to $7.2 million. The company is projected to achieve profitability by 2025, with anticipated profits of $5.8 million and potential breakeven next year. For this trajectory, Aytu must sustain